Can’t say it hasn’t been an interesting Q1 2023, right? With the New Year getting off to a sizzling start, and yet investor sentiment remaining rather suspect, some “payback” was likely in store in February. After all, markets don’t tend to go up in a straight line. Overbought conditions will develop during a strong uptrend, and those overbought conditions usually…
Three trading weeks have been logged in the New Year and with that… still no signs of increasing volatility...
The US equity market continues to ride the wave of liquidity and seasonal FOMO. As we approach our bull...
Waking From A Slumber? We’re very skeptical that the rally from last October’s low represents the first leg of...
Despite all the uncertainty across today’s global capital markets, we are poised to enter 2023 with a more constructive...
Cross-Asset Strategy: As we indicated in a previous report, a combination of a strong recovery in demand, easy policy,...
Cross-asset Strategy: While the geopolitical crisis and policy tightening are overhangs, risk assets have a number of supports that...
To kick off the MS Global Healthcare Conference, onSeptember 14, Risinger and Harrison hosted former FDACommissioner Dr. Scott Gottlieb...
Just 10 days ago, the Federal Reserve signaled a likely pause in the rate hiking campaign to fight inflation....
JPM Market Recap
$0.00
JPM Research Note
$0.00
JP Morgan Market Volatility Report
$0.00
MarketWatch.com – Top Stories
